Chalcone Derivatives: Promising Starting Points for Drug Design
AbstractMedicinal chemists continue to be fascinated by chalcone derivatives because of their simple chemistry, ease of hydrogen atom manipulation, straightforward synthesis, and a variety of promising biological activities. However, chalcones have still not garnered deserved attention, especially considering their high potential as chemical sources for designing and developing new effective drugs. In this review, we summarize current methodological developments towards the design and synthesis of new chalcone derivatives and state-of-the-art medicinal chemistry strategies (bioisosterism, molecular hybridization, and pro-drug design). We also highlight the applicability of computer-assisted drug design approaches to chalcones and address how this may contribute to optimizing research outputs and lead to more successful and cost-effective drug discovery endeavors. Lastly, we present successful examples of the use of chalcones and suggest possible solutions to existing limitations. View Full-Text
Share & Cite This Article
Gomes, M.N.; Muratov, E.N.; Pereira, M.; Peixoto, J.C.; Rosseto, L.P.; Cravo, P.V.L.; Andrade, C.H.; Neves, B.J. Chalcone Derivatives: Promising Starting Points for Drug Design. Molecules 2017, 22, 1210.
Gomes MN, Muratov EN, Pereira M, Peixoto JC, Rosseto LP, Cravo PVL, Andrade CH, Neves BJ. Chalcone Derivatives: Promising Starting Points for Drug Design. Molecules. 2017; 22(8):1210.Chicago/Turabian Style
Gomes, Marcelo N.; Muratov, Eugene N.; Pereira, Maristela; Peixoto, Josana C.; Rosseto, Lucimar P.; Cravo, Pedro V.L.; Andrade, Carolina H.; Neves, Bruno J. 2017. "Chalcone Derivatives: Promising Starting Points for Drug Design." Molecules 22, no. 8: 1210.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.